Cuproplasia and cuproptosis, two sides of the coin
Cancer Communications · 2025-05 · 45 (5) · 505-524
DOI: 10.1002/cac2.70001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 25.01.2025. Verfasst von Kaizhong Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases, Cancer Center of Zhejiang…. Hauptthemen laut MEDLINE: Copper, Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Copper is an essential micronutrient in the human body, mainly acting as a crucial cofactor required for a wide range of physiological processes across nearly all cell types. Recent advances revealed that tumor cells seize copper to fulfill their rapid proliferation, metastasis, immune evasion, and so on by reprogramming the copper regulatory network, defined as cuproplasia. Thus, targeting copper chelation to reduce copper levels has been considered a rational tumor therapy strategy. However, overloaded copper ions could be toxic, which leads to the aggregation of lipoylated mitochondrial proteins and the depletion of iron‐sulfur clusters, ultimately resulting in cell death, termed cuproptosis. Upon its discovery, cuproptosis has attracted great interest from oncologists, and targeting cuproptosis by copper ionophores exhibits as a potential anti‐tumor therapy. In this review, we present the underlying mechanisms involved in cuproplasia and cuproptosis. Additionally, we sum up the chemicals targeting either cuproplasia or cuproptosis for cancer therapy. Further attention should be paid to distinguishing cancer patients who are suitable for targeting cuproplasia or cuproptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases, Cancer Center of Zhejiang University, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang U…
- Department of Oncology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province, Hangzhou, Zhejiang, P. R. China.
- Key Laboratory for Research on the Pathogenesis of Inflammation-Cancer Transformation in Intestinal Diseases, Zhejiang Engineering Research Center of Intelligent Equipment of Chronic Chinese and Western Medicine, Hangzh…
ORCID-Profile: Kaizhong Lu, Lifeng Feng
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Lu, K., Wijaya, C. S., Yao, Q., Jin, H., & Feng, L. (2025). Cuproplasia and cuproptosis, two sides of the coin. Cancer Communications, 45(5), 505-524. https://doi.org/10.1002/cac2.70001
Vancouver
Lu K, Wijaya CS, Yao Q, Jin H, Feng L. Cuproplasia and cuproptosis, two sides of the coin. Cancer Communications. 2025;45(5):505-524. doi:10.1002/cac2.70001
BibTeX
@article{Lu2025,
author = {Lu, Kaizhong and Wijaya, Chandra Sugiarto and Yao, Qinghua and Jin, Hongchuan and Feng, Lifeng},
title = {Cuproplasia and cuproptosis, two sides of the coin},
journal = {Cancer Communications},
year = {2025},
volume = {45},
number = {5},
pages = {505--524},
doi = {10.1002/cac2.70001}
}
EUVIMED